Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to $145.3 million.

  • Neogen's Cash & Equivalents rose 364.33% to $145.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $145.3 million, marking a year-over-year increase of 364.33%. This contributed to the annual value of $129.0 million for FY2025, which is 2438.71% down from last year.
  • Neogen's Cash & Equivalents amounted to $145.3 million in Q4 2025, which was up 364.33% from $138.9 million recorded in Q3 2025.
  • Neogen's 5-year Cash & Equivalents high stood at $205.8 million for Q4 2023, and its period low was $42.9 million during Q1 2022.
  • Its 5-year average for Cash & Equivalents is $115.7 million, with a median of $124.1 million in 2024.
  • As far as peak fluctuations go, Neogen's Cash & Equivalents crashed by 5510.64% in 2021, and later skyrocketed by 26705.42% in 2023.
  • Over the past 5 years, Neogen's Cash & Equivalents (Quarter) stood at $51.1 million in 2021, then surged by 95.62% to $100.0 million in 2022, then skyrocketed by 105.76% to $205.8 million in 2023, then plummeted by 31.85% to $140.2 million in 2024, then rose by 3.64% to $145.3 million in 2025.
  • Its Cash & Equivalents was $145.3 million in Q4 2025, compared to $138.9 million in Q3 2025 and $129.0 million in Q2 2025.